Induction Healthcare Group PLC
(“Induction”, the “Company”, or the “Group”)
Notice of Half-year results
Investor Presentation
Induction (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, will announce its half-year results for six months ended 30 September 2022 on Monday 5 December 2022. Investor PresentationThe Company will be hosting a live online presentation relating to the half-year results via the Investor Meet Company platform at 4pm (GMT) on Monday 5 December 2022. The presentation is open to all existing and potential shareholders.Investors can sign up to Investor Meet Company for free and register for the presentation here: https://www.investormeetcompany.com/induction-healthcare-group-plc/register-investor.Investors who already follow Induction on the Investor Meet Company platform will automatically be invited.Questions can be submitted pre-event via your IMC dashboard or in real time during the presentation, via the "Ask a Question" function. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.ENQUIRIESInductionJames Balmain, Chief Executive OfficerGuy Mitchell, Chief Financial OfficerVia Walbrook PR Ltd: induction@walbrookpr.com Singer Capital Markets (Nominated Adviser and Broker)+44 (0)20 7496 3000Philip Davies / Kailey Aliyar Walbrook PR Ltd induction@walbrookpr.comPaul McManus / Alice WoodingsMob: +44(0)7980 541 893 / +44 (0)7407 804 654 About Induction - www.inductionhealthcare.comInduction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face – giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.
